Source:http://linkedlifedata.com/resource/pubmed/id/11919577
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2002-3-28
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1529-2908
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
3
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
344-5
|
| pubmed:dateRevised |
2007-11-8
|
| pubmed:meshHeading |
pubmed-meshheading:11919577-Animals,
pubmed-meshheading:11919577-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11919577-Diabetes Mellitus, Type 1,
pubmed-meshheading:11919577-Disease Models, Animal,
pubmed-meshheading:11919577-Histocompatibility Antigens Class II,
pubmed-meshheading:11919577-Humans,
pubmed-meshheading:11919577-Mice,
pubmed-meshheading:11919577-Peptides
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Class II peptide multimers: promise for type 1A diabetes?
|
| pubmed:publicationType |
Comment,
News
|